Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may increase the risk of pulmonary aspiration among patients undergoing surgery ...

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

“[GLP-1] plays a key in regulating blood sugar and body weight,” Almandoz said. “These medications work from a weight perspective by slowing gastric emptying, which helps people feel full ...

Their guidance arose from the known delayed gastric emptying effects of these medications ... Consistent with the multi-society guidance on GLP-1 receptor agonists, the new MIPS measure, ABG ...

When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...

Related FDA approves weight-loss drug Zepbound to treat sleep apnea FDA says shortage of GLP-1 drug tirzepatide ... slowing of gastric emptying, which increases a feeling of fullness, and arousing ...

The medications are known as glucagon-like peptide-1 receptor agonists (GLP-1RA ... releasing glucose-stimulated insulin, slowing of gastric emptying, which increases a feeling of fullness ...

UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...

Story continues below this ad GLP-1 is a natural hormone in our body that plays a role ... concurred and shared that these drugs help in delaying gastric emptying, increasing satiety and appetite ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.